Hologic (HOLX) volatility elevated into Q4 results and sales outlook

November 1, 2011 11:40 AM EDT
Hologic (Nasdaq: HOLX) is expected to release Q4 results on November 7. Citigroup Global Markets maintains its Buy rating and $21 price target on HOLX. November put option implied volatility is at 65, December is at 55; above its 26-week average of 41 according to Track Data.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Options

Related Entities

Citi, Options